首页> 外国专利> METHOD FOR ASSESSMENT OF MYCOBACTERIUM TUBERCULOSIS MEDICINAL SENSITIVITY BASED ON RESULTS OF BLOOD IMMUNOLOGICAL INDICES DETERMINATION IN PATIENT WITH PULMONARY TUBERCULOSIS

METHOD FOR ASSESSMENT OF MYCOBACTERIUM TUBERCULOSIS MEDICINAL SENSITIVITY BASED ON RESULTS OF BLOOD IMMUNOLOGICAL INDICES DETERMINATION IN PATIENT WITH PULMONARY TUBERCULOSIS

机译:基于肺结核患者血液免疫指标测定结果的结核分枝杆菌药物敏感性评估方法

摘要

FIELD: medicine.;SUBSTANCE: method for assessment of Mycobacterium tuberculosis medicinal sensitivity of based on the results of blood immunological indices determination in a patient with pulmonary tuberculosis includes a blood test in which the absolute amount of phagocytic granulocytes and T lymphocytes expressing the HLA-DR-Ag late activation marker is established. The results are calculated by the formula Y=1.76-5.08X1-0.17X2, where X1 is CD3+HLA-DR+(109/liter), X2 is the number of phagocytic granulocytes (109/liter). At a value of Y1, a conclusion is made about the medicine-sensitive isolates of the tuberculosis causative agent, and at Y≥1 - about isolates without medicinal sensibility.;EFFECT: application of this invention allows to assess Mycobacterium tuberculosis medicinal sensitivity without performing bacteriological tests, which reduces the variability of data between the test samples.;4 ex
机译:领域:医学。对象:基于肺结核患者血液免疫学指标测定结果评估结核分枝杆菌药物敏感性的方法包括一项血液测试,其中绝对量的吞噬性粒细胞和表达HLA-建立了DR-Ag晚期激活标记。结果由公式Y = 1.76-5.08X1-0.17X2计算得出,其中X1是CD3 + HLA-DR + (10 9 /升),X2是吞噬粒细胞的数量(10 9 /升)。在Y <1时,得出关于结核病致病菌的药物敏感分离物的结论,在Y≥1时,得出关于无药敏性的分离物的结论。效果:本发明的应用允许评估结核分枝杆菌的药敏性。无需进行细菌学测试,从而降低了测试样品之间数据的差异性; 4 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号